On Tuesday, Unitrin hit a pre-established trigger point and the second lot of the trade was sold at $31.47 net of commissions. This lot of the trade was up 33% in about 5 months. The S&P 500 was up nearly 13% during the same period.
The stock now seems more fairly valued. The portfolio no longer holds any Unitrin.
Both lots of this trade performed well as the the total trade gained approximately 30% and easily outperformed the S&P over the holding period